
Cutspas-C Tablet
Marketer
Monark Biocare Pvt Ltd
Salt Composition
Clidinium (2.5mg) + Chlordiazepoxide (5mg) + Dicyclomine (10mg)
Overview Cutspas-C Tablet
Colispas-M Tablets are indicated for managing irritable bowel syndrome, characterized by abdominal pain, cramping, distension, and altered bowel habits (diarrhea or constipation). This medication works by inhibiting abrupt muscle spasms, thus alleviating stomach pain and cramping. It also facilitates gas expulsion, mitigating abdominal discomfort. Colispas-M Tablets should be ingested on an empty stomach, following the dosage and regimen prescribed by your physician. Your prescribed dose will be tailored to your individual needs and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Commonly reported side effects include nausea, constipation, anxiety, dry mouth, urinary difficulty, disorientation, fatigue, blurred vision, and impaired coordination. Most side effects are transient and self-limiting. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness may occur; refrain from operating machinery or engaging in activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Lifestyle adjustments, such as a high-fiber diet, avoidance of trigger foods, increased hydration, and regular physical activity, can enhance therapeutic outcomes. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, as well as pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Cutspas-C Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cutspas-C Tablet
Managing irritable bowel syndrome
Major Benefits of Cutspas-C Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cutspas-C Tablet on an empty stomach.
Common Side effects of Cutspas-C Tablet:
- Nausea
- Constipation
- Nervousness
- Dryness in mouth
- Difficulty in urination
- Confusion
- Sleepiness
- Weakness
- Dizziness
- Blurred vision
- Impaired coordination
How to use Cutspas-C Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cutspas-C Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer Cutspas-C on an empty stomach.
How Cutspas-C Tablet works:
Cutspas-C Tablets contain a triple-action formula: clidinium, chlordiazepoxide, and dicyclomine. The antispasmodics, clidinium and dicyclomine, ease intestinal and stomach muscle tension, thereby alleviating spasms and the associated cramping, pain, distension, and discomfort. Chlordiazepoxide, a benzodiazepine, enhances GABA neurotransmission, reducing overactive brain cell signaling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cutspas-C Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Cutspas-C tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Cutspas-C tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Cutspas-C Tablet side effects, such as drowsiness or reduced concentration. This medication's potential to induce drowsiness could negatively impact driving capabilities.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Cutspas-C Tablets. A modified dosage of Cutspas-C Tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Cutspas-C Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Cutspas-C Tablet :
Should you forget a Cutspas-C Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cutspas-C Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Gastrointestinal system |
